Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model
| Status: | Completed |
|---|---|
| Conditions: | Allergy, Ocular |
| Therapuetic Areas: | Ophthalmology, Otolaryngology |
| Healthy: | No |
| Age Range: | 10 - Any |
| Updated: | 9/15/2017 |
| Start Date: | May 2010 |
| End Date: | July 2010 |
A Multi-Center, Randomized, Double-Masked Evaluation of the Efficacy of Cetirizine 0.1%/Fluticasone 0.005% Ophthalmic Solution Compared to Its Components and Vehicle in a Modified Conjunctival Allergen Challenge (CAC) Model During Pollen Season
The purpose of this study is to evaluate the efficacy of AC-150 compared to vehicle and its
components in the prevention of the signs and symptoms of allergic conjunctivitis in
Enviro-CAC™ Model.
components in the prevention of the signs and symptoms of allergic conjunctivitis in
Enviro-CAC™ Model.
Inclusion Criteria:
- Positive bilateral conjunctival allergen challenge(CAC) reaction
Exclusion Criteria:
- Known contraindications or sensitivities to the study medication or its components.
- Any ocular condition that, in the opinion of the investigator, could affect the
subjects safety or trial parameters.
- Use of disallowed medications during the period indicated prior to study enrollment or
during the study.
We found this trial at
1
site
Click here to add this to my saved trials
